These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
346 related items for PubMed ID: 22281731
1. Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas. Ellingson BM, Zaw T, Cloughesy TF, Naeini KM, Lalezari S, Mong S, Lai A, Nghiemphu PL, Pope WB. J Magn Reson Imaging; 2012 Jun; 35(6):1472-7. PubMed ID: 22281731 [Abstract] [Full Text] [Related]
2. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas. Thomsen H, Steffensen E, Larsson EM. Acta Radiol; 2012 Feb 01; 53(1):95-101. PubMed ID: 22114021 [Abstract] [Full Text] [Related]
3. Partial-volume model for determining white matter and gray matter cerebral blood volume for analysis of gliomas. Lee MC, Cha S, Chang SM, Nelson SJ. J Magn Reson Imaging; 2006 Mar 01; 23(3):257-66. PubMed ID: 16456821 [Abstract] [Full Text] [Related]
6. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI. Fayed N, Dávila J, Medrano J, Olmos S. Eur J Radiol; 2008 Sep 01; 67(3):427-33. PubMed ID: 18442889 [Abstract] [Full Text] [Related]
7. Attempts to improve absolute quantification of cerebral blood flow in dynamic susceptibility contrast magnetic resonance imaging: a simplified T1-weighted steady-state cerebral blood volume approach. Wirestam R, Knutsson L, Risberg J, Börjesson S, Larsson EM, Gustafson L, Passant U, Ståhlberg F. Acta Radiol; 2007 Jun 01; 48(5):550-6. PubMed ID: 17520432 [Abstract] [Full Text] [Related]
8. Diagnostic performance of advanced MRI in differentiating high-grade from low-grade gliomas in a setting of routine service. Chawalparit O, Sangruchi T, Witthiwej T, Sathornsumetee S, Tritrakarn S, Piyapittayanan S, Chaicharoen P, Direksunthorn T, Charnchaowanish P. J Med Assoc Thai; 2013 Oct 01; 96(10):1365-73. PubMed ID: 24350420 [Abstract] [Full Text] [Related]
9. Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3T. Ingrisch M, Sourbron S, Morhard D, Ertl-Wagner B, Kümpfel T, Hohlfeld R, Reiser M, Glaser C. Invest Radiol; 2012 Apr 01; 47(4):252-8. PubMed ID: 22373532 [Abstract] [Full Text] [Related]
10. Pixel-by-Pixel Comparison of Volume Transfer Constant and Estimates of Cerebral Blood Volume from Dynamic Contrast-Enhanced and Dynamic Susceptibility Contrast-Enhanced MR Imaging in High-Grade Gliomas. Alcaide-Leon P, Pareto D, Martinez-Saez E, Auger C, Bharatha A, Rovira A. AJNR Am J Neuroradiol; 2015 May 01; 36(5):871-6. PubMed ID: 25634715 [Abstract] [Full Text] [Related]
11. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis. Santarosa C, Castellano A, Conte GM, Cadioli M, Iadanza A, Terreni MR, Franzin A, Bello L, Caulo M, Falini A, Anzalone N. Eur J Radiol; 2016 Jun 01; 85(6):1147-56. PubMed ID: 27161065 [Abstract] [Full Text] [Related]
12. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas. Young R, Babb J, Law M, Pollack E, Johnson G. J Magn Reson Imaging; 2007 Oct 01; 26(4):1053-63. PubMed ID: 17896374 [Abstract] [Full Text] [Related]
15. Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging. Ozsunar Y, Mullins ME, Kwong K, Hochberg FH, Ament C, Schaefer PW, Gonzalez RG, Lev MH. Acad Radiol; 2010 Mar 01; 17(3):282-90. PubMed ID: 20060750 [Abstract] [Full Text] [Related]
16. Experimental estimates of the constants relating signal change to contrast concentration for cerebral blood volume by T2* MRI. Newman GC, Hospod FE, Patlak CS, Fain SE, Pulfer KA, Cook TD, O'Sullivan F. J Cereb Blood Flow Metab; 2006 Jun 01; 26(6):760-70. PubMed ID: 16319833 [Abstract] [Full Text] [Related]
17. Regional and voxel-wise comparisons of blood flow measurements between dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) and arterial spin labeling (ASL) in brain tumors. White CM, Pope WB, Zaw T, Qiao J, Naeini KM, Lai A, Nghiemphu PL, Wang JJ, Cloughesy TF, Ellingson BM. J Neuroimaging; 2014 Jun 01; 24(1):23-30. PubMed ID: 22672084 [Abstract] [Full Text] [Related]
18. Hypervascular tumor volume estimated by comparison to a large-scale cerebral blood volume radiographic atlas predicts survival in recurrent glioblastoma treated with bevacizumab. Leu K, Enzmann DR, Woodworth DC, Harris RJ, Tran AN, Lai A, Nghiemphu PL, Pope WB, Cloughesy TF, Ellingson BM. Cancer Imaging; 2014 Nov 14; 14(1):31. PubMed ID: 25608485 [Abstract] [Full Text] [Related]
19. MR evaluation of vessel size imaging of human gliomas: Validation by histopathology. Kellner E, Breyer T, Gall P, Müller K, Trippel M, Staszewski O, Stein F, Saborowski O, Dyakova O, Urbach H, Kiselev VG, Mader I. J Magn Reson Imaging; 2015 Oct 14; 42(4):1117-25. PubMed ID: 25683112 [Abstract] [Full Text] [Related]
20. Human cerebral blood volume measurements using dynamic contrast enhancement in comparison to dynamic susceptibility contrast MRI. Artzi M, Liberman G, Nadav G, Vitinshtein F, Blumenthal DT, Bokstein F, Aizenstein O, Ben Bashat D. Neuroradiology; 2015 Jul 14; 57(7):671-8. PubMed ID: 25845809 [Abstract] [Full Text] [Related] Page: [Next] [New Search]